The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype

Biomaterials

Volumn 29, Issue 3, 2008, Pages 314-326

  Adelöw, Catharina ^a   Segura, Tatiana ^a,b   Hubbell, Jeffrey A ^a   Frey, Peter ^a,c  

^a EPFL   (Switzerland)

^b University of California   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Bladder; ECM; Hydrogel; Mesenchymal stem cell; PEG; Smooth muscle cell

Indexed keywords

BIOMATERIALS; CELLS; POLYETHYLENE GLYCOLS;

MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL; SMOOTH MUSCLE CELL;

HYDROGELS;

ALPHA SMOOTH MUSCLE ACTIN; MACROGOL; THY 1 ANTIGEN;

ARTICLE; BIODEGRADABILITY; BLADDER RECONSTRUCTION; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL FATE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE CULTURE; TISSUE ENGINEERING; UPREGULATION;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; EXTRACELLULAR MATRIX; HUMANS; HYDROGELS; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; MESENCHYMAL STEM CELLS; METALLOENDOPEPTIDASES; MYOCYTES, SMOOTH MUSCLE; PEPTIDES; PHENOTYPE; POLYETHYLENE GLYCOLS;

EID: 35848960798     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.09.036     Document Type: Article

References (55)

1. Hensle T.W., and Gilbert S.M. A review of metabolic consequences and long-term complications of enterocystoplasty in children. Curr Urol Rep 8 (2007) 157-162
2. Mingin G.C., Stock J.A., and Hanna M.K. Gastrocystoplasty: long-term complications in 22 patients. J Urol 162 (1999) 1122-1125
3. Atala A. Bladder regeneration by tissue engineering. Br J Urol Int 88 (2001) 765-770
4. Schurch W., Seemayer T.A., and Gabbiani G. The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 22 (1998) 141-147
5. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200 (2003) 500-503
6. Desmouliere A. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19 (1995) 471-476
7. Desmouliere A., Chaponnier C., and Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13 (2005) 7-12
8. Gerharz E.W., Turner W.H., Kalble T., and Woodhouse C.R. Metabolic and functional consequences of urinary reconstruction with bowel. Br J Urol Int 91 (2003) 143-149
9. Upadhyay J., Aitken K.J., Damdar C., Bolduc S., and Bagli D.J. Integrins expressed with bladder extracellular matrix after stretch injury in vivo mediate bladder smooth muscle cell growth in vitro. J Urol 169 (2003) 750-755
10. Adam R.M. Recent insights into the cell biology of bladder smooth muscle. Nephron Exp Nephrol 102 (2006) e1-e7
11. Hedin U., Sjolund M., Hultgardh-Nilsson A., and Thyberg J. Changes in expression and organization of smooth-muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. Differentiation 44 (1990) 222-231
12. Mahoney W.M., and Schwartz S.M. Defining smooth muscle cells and smooth muscle injury. J Clin Invest 115 (2005) 221-224
13. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75 (1995) 487-517
14. Andersson K.-E., and Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84 (2004) 935-986
15. Kropp B.P., Zhang Y., Tomasek J.J., Cowan R., Furness 3rd P.D., Vaughan M.B., et al. Characterization of cultured bladder smooth muscle cells: assessment of in vitro contractility. J Urol 162 (1999) 1779-1784
16. Bendeck M.P., Irvin C., Reidy M., Smith L., Mulholland D., Horton M., et al. Smooth muscle cell matrix metalloproteinase production is stimulated via {alpha}v{beta}3 integrin. Arterioscler Thromb Vasc Biol 20 (2000) 1467-1472
17. Baskin L.S., Howard P.S., Duckett J.W., Snyder H.M., and Macarak E.J. Bladder smooth muscle cells in culture: I. identification and characterization. J Urol 149 (1993) 190-197
18. Lutolf M.P., and Hubbell J.A. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. Biomacromolecules 4 (2003) 713-722
19. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Natl Biotechnol 23 (2005) 47-55
20. Chen C.S., Tan J., and Tien J. Mechanotransduction at cell-matrix and cell-cell contacts. Annu Rev Biomed Eng 6 (2004) 275-302
21. Arora P.D., Narani N., and McCulloch C.A.G. The compliance of collagen gels regulates transforming growth factor-ß induction of {alpha}-smooth muscle actin in fibroblasts. Am J Pathol 154 (1999) 871-882
22. Bryant S.J., Anseth K.S., Lee D.A., and Bader D.L. Crosslinking density influences the morphology of chondrocytes photoencapsulated in PEG hydrogels during the application of compressive strain. J Orthop Res 22 (2004) 1143-1149
23. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Natl Biotechnol 21 (2003) 513-518
24. Seliktar D., Zisch A.H., Lutolf M.P., Wrana J.L., and Hubbell J.A. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A 68 (2004) 704-716
25. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. Faseb J 17 (2003) 2260-2262
26. Park Y., Lutolf M.P., Hubbell J.A., Hunziker E.B., and Wong M. Bovine primary chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tissue Eng 10 (2004) 515-522
27. McCarthy L.S., Smeulders N., and Wilcox D.T. Cell biology of bladder development and the role of the extracellular matrix. Nephron Exp Nephrol 95 (2003) e129-e133
28. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288 (2001) 413-419
29. Raeber G.P., Lutolf M.P., and Hubbell J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 89 (2005) 1374-1388
30. Piao M., and Tokunaga O. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb 13 (2006) 82-89
31. Ma X., Labinaz M., Goldstein J., Miller H., Keon W.J., Letarte M., et al. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-ß-induced inhibition of smooth muscle cell migration. Thromb AtheroScl Vasc Biol 20 (2000) 2546-2552
32. Hirose M., Kosugi H., Nakazato K., and Hayashi T. Restoration to a quiescent and contractile phenotype from a proliferative phenotype of myofibroblast-like human aortic smooth muscle cells by culture on type IV collagen gels. J Biochem (Tokyo) 125 (1999) 991-1000
33. Ma X., Wang Y., and Stephens N.L. Serum deprivation induces a unique hypercontractile phenotype of cultured smooth muscle cells. Am J Physiol Cell Physiol 274 (1998) 1206-1214
34. Han M., Wen J.K., Zheng B., Cheng Y., and Zhang C. Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol Cell Physiol 291 (2006) C50-C58
35. Brakebusch C., Bouvard D., Stanchi F., Sakai T., and Fassler R. Integrins in invasive growth. J Clin Invest 109 (2002) 999-1006
36. Garcia A.J. Get a grip: integrins in cell-biomaterial interactions. Biomaterials 26 (2005) 7525-7529
37. Moiseeva E.P. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovascular Research 52 (2001) 372-386
38. Deb A., Skelding K.A., Wang S., Reeder M., Simper D., and Caplice N.M. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 110 (2004) 2673-2677
39. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10 (2003) 228-241
40. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12 (1996) 697-715
41. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100 (2003) 5413-5418
42. Peyton S.R., Raub C.B., Keschrumrus V.P., and Putnam A.J. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 27 (2006) 4881-4893
43. Pickering J.G., Chow L.H., Li S., Rogers K.A., Rocnik E.F., Zhong R., et al. alpha5beta1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury. Am J Pathol 156 (2000) 453-465
44. Massia S.P., and Hubbell J.A. An Rgd spacing of 440 nm is sufficient for integrin alpha-V-beta-3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 114 (1991) 1089-1100
45. Yamamoto M., Yamato M., Aoyagi M., and Yamamoto K. Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells. Exper Cell Res 219 (1995) 249-256
46. Seki J., Koyama N., Kovach N.L., Yednock T., Clowes A.W., and Harlan J.M. Regulation of beta1-integrin function in cultured human vascular smooth muscle cells. Circ Res 78 (1996) 596-605
47. Davenpeck K.L., Marcinkiewicz C., Wang D., Niculescu R., Shi Y., Martin J.L., et al. Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circ Res 88 (2001) 352-358
48. Hedin U., and Thyberg J. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 33 (1987) 239-246
49. Blindt R., Krott N., Hanrath P., vom Dahl J., van Eys G., and Bosserhoff A.-K. Expression patterns of integrins on quiescent and invasive smooth muscle cells and impact on cell locomotion. J Mol Cell Cardiol 34 (2002) 1633-1644
50. Matsuno H., Ishisaki A., Nakajima K., and Kozawa O. Effect of a synthetic matrix metalloproteinase inhibitor (ONO-4817) on neointima formation in hypercholesterolemic hamsters. J Cardiovasc Pharmacol 44 (2004) 57-65
51. Blindt R., Vogt F., Lamby D., Zeiffer U., Krott N., Hilger-Eversheim K., et al. Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vas Res 39 (2002) 340-352
52. Yoshida Y., Mitsumata M., Ling G., Jiang J., and Shu Q. Migration of medial smooth muscle cells to the intima after balloon injury. Ann N Y Acad Sci 811 (1997) 459-470
53. Palumbo R., Gaetano C., Melillo G., Toschi E., Remuzzi A., and Capogrossi M.C. Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 102 (2000) 225-230
54. Zhang A., Meng L., Wang Q., Xi L., Chen G., Wang S., et al. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Oncol Rep 15 (2006) 831-836
55. Vasala K., Paakko P., and Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology 62 (2003) 952-957